Hyo S. Han

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

Véronique Dièras, Hyo S. Han, Bella Kaufman et al. · The Lancet Oncology · 2020 · 306 citations · Full text

Breast Oncology, Medicine, Pharmacology +6

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 300 citations · Full text

I-spy2 Trial, Breast Oncology, Medicine +7

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 207 citations · Full text

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

Hatem Soliman, Erica L. Jackson, Tony Neuger et al. · Oncotarget · 2014 · 170 citations · Full text

High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens

Hyo S. Han, Maricer P. Escalón, Bernard Hsiao et al. · Annals of Oncology · 2008 · 153 citations · Full text

Positron Emission Tomography, Lymphoid Neoplasia, False-positive Pet Scans +9